Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |
| FY2019 | 80.1% | -19.6% | -33.4% |
| FY2020 | 82.7% | 4.3% | -10.4% |
| FY2021 | 57.4% | -53.4% | -71.9% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |
| FY2019 | 80.1% | -19.6% | -33.4% |
| FY2020 | 82.7% | 4.3% | -10.4% |
| FY2021 | 57.4% | -53.4% | -71.9% |